FDA Drug recall D-1703-2012
Famotidine Tablets USP, 20 mg, 100 count bottles, Rx Only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. NDC 0378-3020-01
- FDA Drug
- Class III
- terminated
- Published 2012-10-10
On 2012-10-10 the FDA classified a Class III recall of Famotidine Tablets USP, 20 mg, 100 count bottles, Rx Only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. NDC 0378-3020-01 by Mylan Pharmaceuticals, citing impurities/Degradation Products: Out of specification results for Related Compound during routine stability testing.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1703-2012 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2012-06-28 |
| Published | 2012-10-10 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Mylan Pharmaceuticals |
| Distribution | US |
Product
Famotidine Tablets USP, 20 mg, 100 count bottles, Rx Only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. NDC 0378-3020-01
Reason
Impurities/Degradation Products: Out of specification results for Related Compound during routine stability testing.
Identifiers
| code_info | Lot: 3018952, Exp 08/12 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1703-2012%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.